DYRK1A as a biomarker and a therapeutic target for cognitive deficits in Down syndrome and Alzheimer’s diseaseJ.M. Delabar,N. Janel,A. Badel,J. Paul, A.S. Rebillat,P. Coskun,J. Busciglio,I. Lott, M. Schubert,M. Sarazin,P. AlexopoulosEuropean Neuropsychopharmacology(2016)引用 0|浏览17暂无评分AI 理解论文溯源树样例生成溯源树,研究论文发展脉络Chat Paper正在生成论文摘要